Finch Therapeutics Group

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FNCH and other ETFs, options, and stocks.

About FNCH

Finch Therapeutics Group, Inc. engages in the development of microbiome drugs. Its platform includes Human-First Discovery that enables reverse translation from clinical data to engineer the composition of the microbiome based on disease-modifying mechanisms.

CEO

Matthew P. Blischak

CEOMatthew P. Blischak

Employees

Employees1

Headquarters

Boston, Massachusetts

HeadquartersBoston, Massachusetts

Founded

2014

Founded2014

Employees

Employees1

FNCH Key Statistics

Market cap

4.48M

Market cap4.48M

Price-Earnings ratio

-0.06

Price-Earnings ratio-0.06

Dividend yield

—

Dividend yield—

Average volume

168.52K

Average volume168.52K

High today

$3.40

High today$3.40

Low today

$2.35

Low today$2.35

Open price

$2.45

Open price$2.45

Volume

692.04K

Volume692.04K

52 Week high

$16.74

52 Week high$16.74

52 Week low

$1.86

52 Week low$1.86

Finch Therapeutics Group

Why Robinhood?

Finch Therapeutics Group, Inc. engages in the development of microbiome drugs. Its platform includes Human-First Discovery that enables reverse translation from clinical data to engineer the composition of the microbiome based on disease-modifying mechanisms. Show more

FNCH Key Statistics

Finch Therapeutics Group, Inc. engages in the development of microbiome drugs. Its platform includes Human-First Discovery that enables reverse translation from clinical data to engineer the composition of the microbiome based on disease-modifying mechanisms.